Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 1994Journal of VirologyOpen Access

Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

Douglas D. Richman
Douglas D. RichmanUniversity of VermontDHDiane V. HavlirUniversity of California, San FranciscoJCJacques CorbeilMila - Quebec Artificial Intelligence Institute

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Richman et al. (1994) studied this question.

synapsesocial.com/papers/6a09bfadb0d552aa8b45de2chttps://doi.org/10.1128/jvi.68.3.1660-1666.1994
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 13'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors1992 · 229 citations
  2. 2A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.1993 · 163 citations
  3. 3Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection1991 · 848 citations
  4. 4Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor1990 · 745 citations
  5. 5Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)1989 · 1,175 citations